Sale!
Replica: Targeted EGFRm NSCLC Treatment with Osimertinib
Replica: Targeted EGFRm NSCLC Treatment with Osimertinib - Image 2

Replica: Targeted EGFRm NSCLC Treatment with Osimertinib

Original price was: $698.00.Current price is: $539.00.

Targeted therapy for NSCLC, Third-generation irreversible EGFR-TKI, Effective against EGFR Ex19Del and L858R mutations, Central nervous system metastasis activity,

SKU: SKU67EFSKFQT Category:
Contact via Email Contact via WhatsApp
Guaranteed Safe Checkout

Targeted therapy for NSCLC, Third-generation irreversible EGFR-TKI, Effective against EGFR Ex19Del and L858R mutations, Central nervous system metastasis activity,

Related products

Scroll to Top